Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

336
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
336
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

242
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
242
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing the pectolinarigenin production in <i>Clerodendrum phlomidis</i> L. f. cell suspension cultures and machine learning-based predictive modeling.

Frontiers in plant science·2026
Same author

Diagnosis and management of allergic rhinitis: An Indian expert consensus by otorhinolaryngologists.

Asia Pacific allergy·2025
Same author

Morphological, molecular, and pharmacological review of veldt grape (<i>Cissus quadrangularis</i> L.): an underutilized medicinal plant.

Frontiers in plant science·2025
Same author

Impact of premorbid nutritional status on TB severity.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Efficacy and safety data on pretomanid for drug-resistant TB.

IJTLD open·2025
Same author

Hypercalcemia in pulmonary drug resistant tuberculosis patient on modified BPaL regimen.

The Indian journal of tuberculosis·2025

Related Experiment Video

Updated: Jul 9, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Role for Linezolid in drug sensitive tuberculosis.

S Ramesh Kumar1, G Narendran2, C Padmapriyadarsini3

  • 1Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Madurai unit, Madurai, India.

Journal of Infection and Public Health
|December 1, 2023
PubMed
Summary

Shortening tuberculosis treatment using linezolid shows promise for drug-sensitive TB (DSTB). This approach may offer a safer, effective alternative to current lengthy treatment regimens.

Keywords:
Clinical trialDrug-sensitive tuberculosisLinezolidResistant tuberculosis

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.9K

Related Experiment Videos

Last Updated: Jul 9, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

11.9K

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Tuberculosis (TB) remains a significant global health issue.
  • Current treatment durations for drug-sensitive TB (DSTB) are lengthy.
  • Linezolid is increasingly recognized for its efficacy in managing resistant TB strains.

Purpose of the Study:

  • To investigate the potential of linezolid in shortening treatment duration for DSTB.
  • To evaluate the favorable bactericidal effects of linezolid in DSTB.
  • To address concerns regarding linezolid's safety and tolerability in shorter treatment regimens.

Main Methods:

  • Review of existing studies on linezolid's use in DSTB.
  • Analysis of reported bactericidal effects and safety profiles.
  • Exploration of clinical trial data on linezolid's safety and tolerability for shorter durations.

Main Results:

  • Linezolid demonstrates favorable bactericidal effects in DSTB.
  • Clinical trials suggest safety and tolerability of linezolid for shorter treatment periods.
  • Limited studies explore linezolid for DSTB, indicating a promising but underexplored area.

Conclusions:

  • Establishing the safety and efficacy of shorter-duration linezolid regimens could revolutionize DSTB treatment.
  • Linezolid presents a potential alternative for shortening DSTB therapy.
  • Further research is warranted to confirm linezolid's role in expedited DSTB treatment.